INR 719.7
(1.92%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 800.77 Million INR | 28.68% |
2022 | 1.2 Billion INR | -54.79% |
2021 | 2.65 Billion INR | 2.29% |
2020 | 2.59 Billion INR | -30.28% |
2019 | 3.72 Billion INR | 2.79% |
2018 | 3.62 Billion INR | -9.23% |
2017 | 3.99 Billion INR | -6.0% |
2016 | 4.24 Billion INR | 1.93% |
2015 | 4.16 Billion INR | -27.67% |
2014 | 5.76 Billion INR | 12.54% |
2013 | 5.11 Billion INR | -14.27% |
2012 | 5.97 Billion INR | -7.86% |
2011 | 6.48 Billion INR | 3.78% |
2010 | 6.24 Billion INR | 399.99% |
2009 | -2.08 Billion INR | -135.37% |
2008 | 5.88 Billion INR | 15.17% |
2007 | 5.11 Billion INR | 22.17% |
2006 | 4.18 Billion INR | 11.62% |
2005 | 3.74 Billion INR | 26.75% |
2004 | 2.95 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 396.58 Million INR | -48.23% |
2023 FY | 1.54 Billion INR | 28.68% |
2023 Q1 | 564.17 Million INR | 139.33% |
2023 Q2 | 609.22 Million INR | 7.99% |
2023 Q3 | 284.09 Million INR | -53.37% |
2023 Q4 | 424.94 Million INR | 49.58% |
2022 FY | 1.2 Billion INR | -54.79% |
2022 Q4 | 235.73 Million INR | -5.17% |
2022 Q1 | 703.69 Million INR | 16.48% |
2022 Q2 | 648.71 Million INR | -7.81% |
2022 Q3 | 248.58 Million INR | -61.68% |
2021 Q4 | 604.11 Million INR | -19.56% |
2021 Q1 | 650.17 Million INR | 180.43% |
2021 FY | 2.65 Billion INR | 2.29% |
2021 Q2 | 651.84 Million INR | 0.26% |
2021 Q3 | 751 Million INR | 15.21% |
2020 FY | 2.59 Billion INR | -30.28% |
2020 Q4 | 231.85 Million INR | -69.92% |
2020 Q3 | 770.87 Million INR | -4.94% |
2020 Q2 | 810.91 Million INR | 3.43% |
2020 Q1 | 784.04 Million INR | 69.33% |
2019 Q1 | 1.13 Billion INR | 0.0% |
2019 FY | 3.72 Billion INR | 2.79% |
2019 Q4 | 463.02 Million INR | -55.79% |
2019 Q2 | 1.08 Billion INR | -4.37% |
2019 Q3 | 1.04 Billion INR | -3.3% |
2018 Q2 | 1.08 Billion INR | 0.0% |
2018 FY | 3.62 Billion INR | -9.23% |
2017 Q2 | 1.05 Billion INR | 0.0% |
2017 FY | 3.99 Billion INR | -6.0% |
2016 FY | 4.24 Billion INR | 1.93% |
2015 FY | 4.16 Billion INR | -27.67% |
2015 Q1 | 1.05 Billion INR | 0.0% |
2014 FY | 5.76 Billion INR | 12.54% |
2013 Q2 | 2.44 Billion INR | 0.0% |
2013 FY | 5.11 Billion INR | -14.27% |
2012 Q4 | 1.57 Billion INR | 0.0% |
2012 Q2 | 1.73 Billion INR | 0.0% |
2012 FY | 5.97 Billion INR | -7.86% |
2011 Q4 | 1.95 Billion INR | 0.0% |
2011 FY | 6.48 Billion INR | 3.78% |
2010 FY | 6.24 Billion INR | 399.99% |
2009 FY | -2.08 Billion INR | -135.37% |
2008 FY | 5.88 Billion INR | 15.17% |
2007 FY | 5.11 Billion INR | 22.17% |
2006 FY | 4.18 Billion INR | 11.62% |
2005 FY | 3.74 Billion INR | 26.75% |
2004 FY | 2.95 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.954% |
Hester Biosciences Limited | 908.84 Million INR | 11.891% |
Aarti Drugs Limited | 1.16 Billion INR | 31.41% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 73.954% |
Albert David Limited | 1.02 Billion INR | 21.963% |
Alembic Limited | 872.45 Million INR | 8.217% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.561% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -75.768% |
Bajaj HealthCare Limited | 985.34 Million INR | 18.732% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -11641.51% |
Brooks Laboratories Limited | 51.18 Million INR | -1464.617% |
Eris Lifesciences Limited | 4.94 Billion INR | 83.8% |
FDC Limited | 3.49 Billion INR | 77.119% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 93.121% |
Gufic Biosciences Limited | 1.18 Billion INR | 32.515% |
Hikal Limited | 4.46 Billion INR | 82.061% |
Ind-Swift Limited | 946.56 Million INR | 15.403% |
Innova Captab Limited | 931.03 Million INR | 13.991% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 63.618% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -82.595% |
Jubilant Pharmova Limited | 14.45 Billion INR | 94.46% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 25.453% |
Lupin Limited | 125.09 Billion INR | 99.36% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -393.608% |
Medico Remedies Limited | 59.67 Million INR | -1241.887% |
Morepen Laboratories Limited | 1.98 Billion INR | 59.709% |
Nectar Lifesciences Limited | 932.7 Million INR | 14.145% |
Procter & Gamble Health Limited | 2.99 Billion INR | 73.267% |
RPG Life Sciences Limited | 1.63 Billion INR | 51.038% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -94.161% |
Sigachi Industries Limited | 579.88 Million INR | -38.091% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 68.648% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 42.916% |
Themis Medicare Limited | 1.12 Billion INR | 28.871% |
Unichem Laboratories Limited | 6.72 Billion INR | 88.094% |
Vaishali Pharma Limited | 84.02 Million INR | -852.97% |
Wanbury Limited | 978.96 Million INR | 18.202% |
Windlas Biotech Limited | 1 Billion INR | 20.441% |
ZIM Laboratories Limited | 1.01 Billion INR | 20.955% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 62.302% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.783% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.481% |
Venus Remedies Limited | 1.91 Billion INR | 58.212% |
Sakar Healthcare Limited | 204.07 Million INR | -292.383% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.561% |
Divi's Laboratories Limited | 14.17 Billion INR | 94.349% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 67.626% |
Mankind Pharma Limited | 29.27 Billion INR | 97.264% |
Sequent Scientific Limited | 2.9 Billion INR | 72.404% |
Laurus Labs Limited | 11.9 Billion INR | 93.276% |
Neuland Laboratories Limited | 2.92 Billion INR | 72.668% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 94.587% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.295% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.36% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 61.759% |
Wockhardt Limited | 8.48 Billion INR | 90.557% |
Bal Pharma Limited | 555.62 Million INR | -44.121% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.165% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 43.577% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1273.817% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 63.174% |
Shilpa Medicare Limited | 3.33 Billion INR | 75.983% |
Valiant Laboratories Limited | 138.02 Million INR | -480.147% |
Ajanta Pharma Limited | 30.46 Billion INR | 97.371% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -5534.074% |
Granules India Limited | 10.31 Billion INR | 92.235% |
Medicamen Biotech Limited | 335.16 Million INR | -138.917% |
Syncom Formulations (India) Limited | 345.63 Million INR | -131.682% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.742% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 96.262% |
NATCO Pharma Limited | 10.05 Billion INR | 92.038% |
Suven Life Sciences Limited | 109.75 Million INR | -629.632% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1634.923% |
Strides Pharma Science Limited | 9.16 Billion INR | 91.26% |
Indoco Remedies Limited | 12.06 Billion INR | 93.361% |
Alpa Laboratories Limited | 127.38 Million INR | -528.647% |
Lasa Supergenerics Limited | 291.17 Million INR | -175.015% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 73.974% |